Saint Louis, MO · Founded 2015 · Privately Held (backing)
Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing. Geneoscopy is based in Saint Louis, MO and was founded in 2015. It was valued at $440 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $218 million across 2 recorded rounds; the latest was a $50.5 million later-stage round in May 2021.
PMV mark · valuation
$440.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$218.4M
Last round
Later Stage VC
May 2021
Team — not yet on record
No current team members for Geneoscopy are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Geneoscopy with a free account
·The complete investor list: 24 names
·Watch Geneoscopy: the Monday email on marks, rounds and moves
